CMV gB/pp65 eVLPs formulated with GM-CSF as a therapeutic vaccine against recurrent GBM
Conference: 2018 Annual Meeting of the Society for Neuro-Oncology (SNO)
Date: October 24, 2018

October 24, 2018 |
CMV gB/pp65 eVLPs formulated with GM-CSF as a therapeutic vaccine against recurrent GBM
Conference: 2018 Annual Meeting of the Society for Neuro-Oncology (SNO)
Date: October 24, 2018
VBI Vaccines to Discuss Progress in Hepatitis B Portfolio in Analyst-Led Fireside Chat